维普中文期刊产品整合服务
83篇 您的检索式:作者名="MOUTON JW"
    题名 作者 年代 出处 被引量
1Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis显示文摘Seyedmousavi S Mouton JW Verweij PE 2013Expert Rev Anti Infect Ther2013,11,9:1
2Comparative pharmacokinetics of the carbapenems: clinical implications显示文摘Mouton JW Touzw DJ Horrevorts AM 2000Clin Pharmacokinet2000,39,3:1
3Standardization of pharmacokinetic/pharmacodynamic(PK/PD) terminology for anti- infective drugs: an update 显示文摘MOUTON JW DUDLEY MN CARS O 2005J Antimicrob Chemother2005,55,5:1
4Potent synergistic in vitro interaction between nonantimicrobial membraneactive compounds and itraconazole against clinical isolates of aspergillus fumigatus resistant to itraconazole显示文摘 Vitale RG Mouton JW 2004Antimicrob Agents Chemother2004,48,4:1
5Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens显示文摘Kluytmans JA Goessens WH Mouton JW 1993J Clin Mierobiol1993,31,12:1
6Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections 显示文摘Buijk SL Gyssens IC Mouton JW 2002J Antimicrob Chemother2002,49,1:1
7Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens 显示文摘Kluytmans JA Goessens WH Mouton JW 1995J Clin Mierobiol1995,31,12:1
8In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates显示文摘 Mouton JW Meis JF 2003Antimicrob Agents Chemother2003,47,1:1
9Standardization ofpharmacokinetic/pharmacodynamic(PK/PD)terminology forantiinfective drugs:an update显示文摘Mouton JW Dudley MN Cars O 2005J Antimicrob Chemother2005,55,5:1
10Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacody- namic perspective 显示文摘Mouton JW Ambrose PG Canton R 2011Drug Resist Updta2011,14,2:1
11Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery显示文摘Kluytmans JA Mouton JW Ijzerman EP 1995J Infect Dis1995,171,1:1
12Comparative pharmacokinetics of the earbapenems:clinical implications显示文摘Mouton JW Touw DJ Horrevorts AM 2000Clin Pharmacokinetics2000,39,:1
13Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia 显示文摘Muller AE Punt N Mouton JW 2013J Antimicrob Chemother2013,68,4:1
14Comprison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo显示文摘Den HollandeeR JG Knudson JD Mouton JW 1998Antimicr Agent Chemother1998,42,:1
15Continuous administration of PBP-2-and PBP-3-specific (beta/-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis显示文摘Buijs J Dofferhoff AS Mouton JW 2007J Antimicrob Chemother2007,59,5:1
16Conserving antibiotics for the future:new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective显示文摘Mouton JW Ambrose PG Canton R 2011Drug Resist Updat2011,14,2:1
17Concentration-depend-ency of p-lactam-induced filament formation in Gram-negativebacteria显示文摘Buijs J Dofferhoff AS Mouton JW 2008Clin Microbiol Infect2008,14,4:1
18Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method显示文摘 JFG M Meis JW Mouton 2000Clin Microbiol2000,38,:1
19Clinical impact of preincubation of blood cultures at 3712 显示文摘van der Velden LB Vos FJ Mouton JW 2011J Clin Microbiol2011,49,:1
20Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis 显示文摘Dannaoui E Mouton JW Meis JF 2002Antimicrob Agents Chemother2002,46,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费